SynthesisBMJ open diabetes research & care2020

Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis.

What the trial testedas reported · 966 people · 2020

Range includes no effect

+4%−8% to +17%

Bigger than 1 in 10 on the map

As reported

OR 1.04, 95% CI 0.92–1.17

Not counted

1.7×1.1× to 2.4×

Bigger than 7 in 10 on the map

As reported

OR 1.66, 95% CI 1.14–2.42

the abstract, start to end

… of NDs with metformin exposure (OR 1.04, 95% CI 0.92 to 1.17).

… users or glitazone users (OR 1.66, 95% CI 1.14 to 2.42).

← favours treatmentfavours comparator →

could be chance

Pharmacokinetics & dosing

OR 1.040.92–1.17

Pharmacokinetics & dosing

OR 1.661.14–2.42

MetforminThiazolidinedionesPharmacokinetics & dosing

1 / 3

2020

2021

2022

2023

2024

2025

2026

this paperpooled itcites it